Crossmark Global Holdings, Inc. Horizon Therapeutics Public LTD CO Transaction History

Crossmark Global Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	BUY	$96.34 - $112.38 $3,660 - $4,270	38 Added 1.88%	2,062 $206,000
Q1 2023 May 12, 2023	BUY	$107.32 - $113.5 $20,498 - $21,678	191 Added 10.42%	2,024 $221,000
Q4 2022 Jan 19, 2023	BUY	$62.39 - $113.8 $114,360 - $208,595	1,833 New	1,833 $209,000
Q2 2022 Jul 29, 2022	SELL	$79.4 - $116.36 $169,519 - $248,428	-2,135 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$86.42 - $109.81 $184,506 - $234,444	2,135 New	2,135 $225,000
Q4 2021 Jan 10, 2022	SELL	$98.56 - $119.91 $720,966 - $877,141	-7,315 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$91.91 - $110.37 $672,321 - $807,356	7,315 New	7,315 $801,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.